Credit Agricole (CRARY)
(Delayed Data from OTC)
$7.76 USD
+0.04 (0.52%)
Updated Apr 29, 2024 03:59 PM ET
3-Hold of 5 3
B Value F Growth B Momentum D VGM
Price, Consensus and EPS Surprise
CRARY 7.76 +0.04(0.52%)
Will CRARY be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for CRARY based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CRARY
Is Credit Agricole (CRARY) Stock Outpacing Its Finance Peers This Year?
Are Investors Undervaluing Credit Agricole (CRARY) Right Now?
CRARY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Credit Agricole (CRARY) Stock Undervalued Right Now?
Are Finance Stocks Lagging Credit Agricole (CRARY) This Year?
Should Value Investors Buy Credit Agricole (CRARY) Stock?
Other News for CRARY
Global company events calendar
Credit Agricole: A Conservative Outlook To Overlook
Finance Brands and Sports Sponsorship. Is It Worth It? Leading financial marketing agency Contentworks investigates.
Crédit Agricole CIB Appoints Giliane Coeurderoy Senior Country Officer for Brazil
GLOBAL BROKER RATINGS: Morgan Stanley ups Adyen; UBS cuts Linde